Cyclopharm Ltd
Company Profile
Business description
Cyclopharm Ltd is a company that engages in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. It operates through the following segments. The Technegas segment involves supplying diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism, and distributor of products to the diagnostic imaging sector. The Molecular Imaging segment offers to produce radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders, and cardiac disease. The firm generates maximum revenue from the Technegas segment.
Contact
Unit 4, 1 The Crescent
Kingsgrove
SydneyNSW2208
AUST: +61 295410411
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2026
Employees
95
Stocks News & Analysis
stocks
Weekly Earnings Wrap: CBA, CSL, MQG and more
stocks
ASX player rallies on small guidance upgrade
stocks
After earnings, is Alphabet stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,151.40 | 54.00 | -0.59% |
| CAC 40 | 8,340.56 | 27.32 | 0.33% |
| DAX 40 | 24,852.69 | 3.46 | -0.01% |
| Dow JONES (US) | 49,694.37 | 427.03 | -0.85% |
| FTSE 100 | 10,402.44 | 69.67 | -0.67% |
| HKSE | 27,032.54 | 233.84 | -0.86% |
| NASDAQ | 22,726.81 | 339.66 | -1.47% |
| Nikkei 225 | 57,091.08 | 548.76 | -0.95% |
| NZX 50 Index | 13,306.47 | 200.81 | -1.49% |
| S&P 500 | 6,872.16 | 69.31 | -1.00% |
| S&P/ASX 200 | 8,928.10 | 44.80 | -0.50% |
| SSE Composite Index | 4,134.01 | 0.01 | -0.00% |